- $437.23m
- $580.80m
- CNY5.39bn
- 40
- 69
- 67
- 60
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 6-K |
Standards: | USG | USG | USG | USG | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,207 | 2,527 | 4,016 | 5,013 | 5,389 |
Cost of Revenue | |||||
Gross Profit | 335 | 1,107 | 1,989 | 2,586 | 2,767 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,667 | 3,326 | 4,974 | 5,799 | 5,856 |
Operating Profit | -460 | -800 | -958 | -786 | -466 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -458 | -796 | -919 | -726 | -539 |
Provision for Income Taxes | |||||
Net Income After Taxes | -460 | -799 | -926 | -740 | -550 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -602 | -1,753 | -996 | -727 | -550 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -637 | -1,753 | -996 | -727 | -550 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -5.2 | -7.37 | -6.98 | -5.77 | -4.3 |